The University of Chicago Header Logo

Connection

James Wallace to Time Factors

Back to Details
This is a "connection" page, showing publications James Wallace has written about Time Factors.
James Wallace
Connection Strength
0.012
Time Factors
  1. Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Feb; 30(1):382-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.